Sustained Effectiveness, Tolerability, and Safety of Long-Term Prophylaxis with Lanadelumab in Hereditary Angioedema: The Prospective, Phase 4, Noninterventional EMPOWER Real-World Study.
Saved in:
| Title: | Sustained Effectiveness, Tolerability, and Safety of Long-Term Prophylaxis with Lanadelumab in Hereditary Angioedema: The Prospective, Phase 4, Noninterventional EMPOWER Real-World Study. |
|---|---|
| Authors: | Bernstein JA; Division of Rheumatology, Allergy, and Immunology, Department of Internal Medicine, University of Cincinnati College of Medicine, 231 Albert Sabin Way, ML#563, Cincinnati, OH, 45267-0563, USA. bernstja@ucmail.uc.edu.; Advanced Allergy Services LLC, Cincinnati, OH, USA. bernstja@ucmail.uc.edu.; Bernstein Clinical Research Center, Cincinnati, OH, USA. bernstja@ucmail.uc.edu., Betschel SD; Division of Clinical Immunology and Allergy, Department of Medicine, University of Toronto, Toronto, ON, Canada., Busse PJ; Division of Allergy and Clinical Immunology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Banerji A; Division of Rheumatology, Allergy and Immunology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Wedner HJ; Division of Allergy & Immunology, Washington University School of Medicine in St Louis, St Louis, MO, USA., Manning M; Allergy, Asthma & Immunology Associates, Ltd., Scottsdale, AZ, USA., Zaragoza-Urdaz RH; University of Puerto Rico School of Medicine and University Pediatric Hospital, San Juan, Puerto Rico., Anderson J; AllerVie Health, Birmingham, AL, USA., Gagnon R; Clinique Spécialisée en Allergie de la Capitale, Quebec, QC, Canada., Baptist AP; Division of Allergy and Immunology, Henry Ford Health, Detroit, MI, USA., Soteres D; Asthma & Allergy Associates, P.C., Colorado Springs, CO, USA., Lumry WR; Allergy and Asthma Research Associates, Dallas, TX, USA., Craig T; Allergy, Asthma and Immunology, Departments of Medicine, Pediatrics and Biomedical Sciences, ACARE International Hereditary Angioedema Resource Center, Penn State University, Hershey, PA, USA.; Vinmec International Hospital, Times City, Hanoi, Vietnam., Petroni D; Seattle Allergy and Asthma Research Institute, Seattle, WA, USA., Hsu FI; Section of Rheumatology, Allergy and Immunology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA., Nova Estepan D; Takeda Development Center Americas, Inc., Lexington, MA, USA., Juethner S; Takeda Pharmaceuticals USA, Inc., Lexington, MA, USA., Watt M; Takeda Development Center Americas, Inc., Lexington, MA, USA., Khutoryansky N; Takeda Development Center Americas, Inc., Lexington, MA, USA., Zuraw BL; Division of Allergy & Immunology, University of California San Diego, La Jolla, CA, USA. |
| Corporate Authors: | EMPOWER Investigators |
| Source: | Advances in therapy [Adv Ther] 2025 Aug; Vol. 42 (8), pp. 3882-3901. Date of Electronic Publication: 2025 Jun 12. |
| Publication Type: | Journal Article; Clinical Trial, Phase IV; Multicenter Study |
| Journal Info: | Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-8652 (Electronic) Linking ISSN: 0741238X NLM ISO Abbreviation: Adv Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40504359 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Sustained Effectiveness, Tolerability, and Safety of Long-Term Prophylaxis with Lanadelumab in Hereditary Angioedema: The Prospective, Phase 4, Noninterventional EMPOWER Real-World Study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Bernstein+JA%22">Bernstein JA</searchLink>; Division of Rheumatology, Allergy, and Immunology, Department of Internal Medicine, University of Cincinnati College of Medicine, 231 Albert Sabin Way, ML#563, Cincinnati, OH, 45267-0563, USA. bernstja@ucmail.uc.edu.; Advanced Allergy Services LLC, Cincinnati, OH, USA. bernstja@ucmail.uc.edu.; Bernstein Clinical Research Center, Cincinnati, OH, USA. bernstja@ucmail.uc.edu.<br /><searchLink fieldCode="AU" term="%22Betschel+SD%22">Betschel SD</searchLink>; Division of Clinical Immunology and Allergy, Department of Medicine, University of Toronto, Toronto, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Busse+PJ%22">Busse PJ</searchLink>; Division of Allergy and Clinical Immunology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Banerji+A%22">Banerji A</searchLink>; Division of Rheumatology, Allergy and Immunology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Wedner+HJ%22">Wedner HJ</searchLink>; Division of Allergy & Immunology, Washington University School of Medicine in St Louis, St Louis, MO, USA.<br /><searchLink fieldCode="AU" term="%22Manning+M%22">Manning M</searchLink>; Allergy, Asthma & Immunology Associates, Ltd., Scottsdale, AZ, USA.<br /><searchLink fieldCode="AU" term="%22Zaragoza-Urdaz+RH%22">Zaragoza-Urdaz RH</searchLink>; University of Puerto Rico School of Medicine and University Pediatric Hospital, San Juan, Puerto Rico.<br /><searchLink fieldCode="AU" term="%22Anderson+J%22">Anderson J</searchLink>; AllerVie Health, Birmingham, AL, USA.<br /><searchLink fieldCode="AU" term="%22Gagnon+R%22">Gagnon R</searchLink>; Clinique Spécialisée en Allergie de la Capitale, Quebec, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Baptist+AP%22">Baptist AP</searchLink>; Division of Allergy and Immunology, Henry Ford Health, Detroit, MI, USA.<br /><searchLink fieldCode="AU" term="%22Soteres+D%22">Soteres D</searchLink>; Asthma & Allergy Associates, P.C., Colorado Springs, CO, USA.<br /><searchLink fieldCode="AU" term="%22Lumry+WR%22">Lumry WR</searchLink>; Allergy and Asthma Research Associates, Dallas, TX, USA.<br /><searchLink fieldCode="AU" term="%22Craig+T%22">Craig T</searchLink>; Allergy, Asthma and Immunology, Departments of Medicine, Pediatrics and Biomedical Sciences, ACARE International Hereditary Angioedema Resource Center, Penn State University, Hershey, PA, USA.; Vinmec International Hospital, Times City, Hanoi, Vietnam.<br /><searchLink fieldCode="AU" term="%22Petroni+D%22">Petroni D</searchLink>; Seattle Allergy and Asthma Research Institute, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Hsu+FI%22">Hsu FI</searchLink>; Section of Rheumatology, Allergy and Immunology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.<br /><searchLink fieldCode="AU" term="%22Nova+Estepan+D%22">Nova Estepan D</searchLink>; Takeda Development Center Americas, Inc., Lexington, MA, USA.<br /><searchLink fieldCode="AU" term="%22Juethner+S%22">Juethner S</searchLink>; Takeda Pharmaceuticals USA, Inc., Lexington, MA, USA.<br /><searchLink fieldCode="AU" term="%22Watt+M%22">Watt M</searchLink>; Takeda Development Center Americas, Inc., Lexington, MA, USA.<br /><searchLink fieldCode="AU" term="%22Khutoryansky+N%22">Khutoryansky N</searchLink>; Takeda Development Center Americas, Inc., Lexington, MA, USA.<br /><searchLink fieldCode="AU" term="%22Zuraw+BL%22">Zuraw BL</searchLink>; Division of Allergy & Immunology, University of California San Diego, La Jolla, CA, USA. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22EMPOWER+Investigators%22">EMPOWER Investigators</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228611864%22">Advances in therapy</searchLink> [Adv Ther] 2025 Aug; Vol. 42 (8), pp. 3882-3901. <i>Date of Electronic Publication: </i>2025 Jun 12. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Clinical Trial, Phase IV; Multicenter Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Health+Communications+Inc%22">Health Communications Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8611864 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1865-8652 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220741238X%22">0741238X </searchLink><i>NLM ISO Abbreviation: </i>Adv Ther <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40504359 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s12325-025-03226-3 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 3882 Titles: – TitleFull: Sustained Effectiveness, Tolerability, and Safety of Long-Term Prophylaxis with Lanadelumab in Hereditary Angioedema: The Prospective, Phase 4, Noninterventional EMPOWER Real-World Study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Bernstein JA – PersonEntity: Name: NameFull: Betschel SD – PersonEntity: Name: NameFull: Busse PJ – PersonEntity: Name: NameFull: Banerji A – PersonEntity: Name: NameFull: Wedner HJ – PersonEntity: Name: NameFull: Manning M – PersonEntity: Name: NameFull: Zaragoza-Urdaz RH – PersonEntity: Name: NameFull: Anderson J – PersonEntity: Name: NameFull: Gagnon R – PersonEntity: Name: NameFull: Baptist AP – PersonEntity: Name: NameFull: Soteres D – PersonEntity: Name: NameFull: Lumry WR – PersonEntity: Name: NameFull: Craig T – PersonEntity: Name: NameFull: Petroni D – PersonEntity: Name: NameFull: Hsu FI – PersonEntity: Name: NameFull: Nova Estepan D – PersonEntity: Name: NameFull: Juethner S – PersonEntity: Name: NameFull: Watt M – PersonEntity: Name: NameFull: Khutoryansky N – PersonEntity: Name: NameFull: Zuraw BL IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 08 Text: 2025 Aug Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1865-8652 Numbering: – Type: volume Value: 42 – Type: issue Value: 8 Titles: – TitleFull: Advances in therapy Type: main |
| ResultId | 1 |
